Clinical Research Directory
Browse clinical research sites, groups, and studies.
Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
Sponsor: Addpharma Inc.
Summary
The study compare and evaluate the safety and pharmacokinetic characteristics of a single dose administration of 'AD-115A' or 'AD-1151' in healthy adults.
Official title: A Randomized, Open-label, Single-dose, Two-sequence, and Two-period Crossover Study to Evaluate the Pharmacokinetics and Safety Between the Administration of AD-115A and the Administration of AD-1151 for Healthy Subjects in Fasting State
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
46
Start Date
2026-01-27
Completion Date
2026-03-16
Last Updated
2026-02-11
Healthy Volunteers
No
Conditions
Interventions
AD-115A, AD-1151
Single-dose oral administration of AD-115A or AD-1151 (200 mg tablet), according to randomized sequence.
Locations (1)
H PLUS YANGJI HOSPITAL, Seoul
Seoul, South Korea